Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Aug 10;11:4747–4754. doi: 10.2147/OTT.S165244

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 Li et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Comparison of the recurrence-free survival curves.

Notes: (A) Patients with MVI positivity combined with high KI-67 show shorter RFS compared with patients with MVI positivity combined with low KI-67. (B) Patients with MVI negativity combined with high KI-67 show no difference compared with patients with MVI negativity combined with low KI-67 in terms of RFS. (C) Patients with MVI positivity combined with high KI-67 show shorter RFS compared with patients with MVI negativity combined with high KI-67. (D) Patients with MVI positivity combined with high KI-67 show shorter RFS compared with patients with MVI negativity combined with low KI-67. (E) Patients with MVI positivity combined with low KI-67 show no difference compared with patients with MVI negativity combined with high KI-67 in terms of RFS. (F) Patients with MVI positivity combined with low KI-67 show no difference compared with patients with MVI negativity combined with low KI-67 in terms of RFS. MVI positivity/high KI-67: MVI positivity and high KI-67 positive cellular index; MVI positivity/low KI-67: MVI positivity and low KI-67 positive cellular index; MVI negativity/high KI-67: MVI negativity and high KI-67 positive cellular index; MVI negativity/low KI-67: MVI negativity and low KI-67 positive cellular index. Results are from Kaplan–Meier analysis. P<0.05 was considered to be statistically significant.

Abbreviations: MVI, microvascular invasion; RFS, recurrence-free survival.